Riskpilot← Back to searchSign inGet full accessLodo Läkarkonsult AB
ABActiveOrg 5569488439Von Sydows Väg 6General medical practice activities · NACE 8621Est. 20131 employees
Revenue 2025
SEK 1,9M
-8% vs 2024
EBITDA margin
20.6%
-34% vs 2024
Equity ratio
66.2%
Financial strength
Net profit 2025
SEK 303K
-35% vs 2024
| Revenue | SEK 1,9M | -8% |
| EBITDA | SEK 385K | -34% |
| Net profit | SEK 303K | -35% |
| Total assets | SEK 1,1M | -16% |
| Equity | SEK 739K | -12% |
| Employees | 1 | — |
Legal name
Lodo Läkarkonsult AB
Org number
5569488439
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
14 november 2013
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-04-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva konsultationer i läkarfrågor, förvaltning av fast och lös egendom samt idka därmed förenlig verksamhet.
Address
Von Sydows Väg 6
Phone
+46768940919
Email
gosia1@home.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 473 | 1 918 | 2 042 | 2 021 | 1 867 |
| Staff expenses | — | — | — | — | −1 026 |
| EBITDA | 298 | 590 | 718 | 584 | 385 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | — |
| EBIT | 298 | 590 | 718 | 584 | 385 |
| Net financials | — | — | — | 1 | −2 |
| Profit before tax | 299 | 590 | 718 | 585 | 383 |
| Tax | −70 | −122 | −169 | −121 | −79 |
| Net profit | 229 | 468 | 549 | 464 | 303 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 569 | 1 022 | 1 296 | 1 322 | 1 116 |
| Equity | 354 | 622 | 772 | 836 | 739 |
| Long-term debt | 0 | 0 | 0 | 0 | — |
| Short-term debt | 215 | 400 | 524 | 486 | 377 |
| Total debt | 215 | 400 | 524 | 486 | 377 |
EBITDA margin
20.6%
This company
15.8%
Market median
+30% vs market
20212025
Equity ratio
66.2%
This company
38.2%
Market median
+73% vs market
20212025
Return on equity
41.0%
This company
18.4%
Market median
+123% vs market
20212025
Net profit margin
16.2%
This company
8.1%
Market median
+100% vs market
20212025
Asset turnover
1.67×
This company
1.12×
Market median
+49% vs market
20212025
Debt / equity
0.51×
This company
0.62×
Market median
+18% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-05-01 – 2021-04-30
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2020 | |
| Board of Directors | 2020 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Lodo Läkarkonsult AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Natalie Mickaela Lorentzson | Deputy Board Member | 0 companies |
| Margareta Julia Lundgren | Board of Directors | 0 companies |